Real-time enrollment status for this carcinoma, hepatocellular clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:04 PM UTC
| NCT Number | NCT07227012 |
| Recruiting Status | Recruiting |
| Condition | Carcinoma, Hepatocellular |
| Phase | PHASE1 |
| Target Enrollment | 138 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | October 8, 2026 (4 days ago) |
As of October 12, 2026: Clinical trial NCT07227012 is currently recruiting participants. This phase1 study for carcinoma, hepatocellular is actively seeking new participants at 46 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07227012 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07227012 was last updated 4 days ago (October 8, 2026). HelloStudys verifies this status automatically.